DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - AEGLEA BIOTHERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of AEGLEA BIOTHERAPEUTICS INC
	Value		Shares		Weighting
Q2 2020	$7,631,000	+98.5%	825,000	+65.0%	0.22%	+41.4%
Q3 2019	$3,845,000	+12.3%	500,046	0.0%	0.16%	+27.6%
Q2 2019	$3,425,000	-14.9%	500,046	0.0%	0.12%	-20.1%
Q1 2019	$4,025,000	–	500,046	–	0.15%	–
Download

Other shareholders

AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2019
Name	Shares	Value	Weighting ↓
Yu Fan	112,044	$50,420	0.68%
Aisling Capital Management LP	1,691,151	$761,018	0.50%
Sio Capital Management, LLC	3,004,959	$1,351,931	0.50%
Bain Capital Life Sciences Investors, LLC	5,347,689	$2,406	0.27%
Ghost Tree Capital, LLC	800,000	$360,000	0.15%
Nantahala Capital Management	4,611,302	$2,074,625	0.13%
Samsara BioCapital, LLC	883,720	$397,586	0.09%
SUVRETTA CAPITAL MANAGEMENT, LLC	4,059,894	$1,826,546	0.08%
SPHERA FUNDS MANAGEMENT LTD.	440,837	$198,333	0.04%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	245,678	$111	0.04%

View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders